Biblio Discovery — Demo Discovery Service

4 results for "Skvarc, David R."

Showing 1–4 · 0.51 seconds · RSS

  1. Journal Article Full text

    Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders

    Dodd, Seetal; Skvarc, David R; Dean, Olivia M et al.

    Int J Neuropsychopharmacol · 2022 · English · PubMed Central

    11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity is implicated as a moderator of the progression of multiple diseases and disorders in medicine and is actively subject to investigation as a therapeutic target. Here we summarize the mechanisms of the enzyme and detail the novel agents…

  2. Journal Article Full text

    Pharmacotherapy in Comorbid Bipolar Disorder and Post‐Traumatic Stress Disorder From the STEP‐BD Cohort

    Russell, Samantha E.; Wrobel, Anna L.; Skvarc, David R. et al.

    Bipolar Disord · 2025 · English · PubMed Central

    INTRODUCTION: Post‐traumatic stress disorder (PTSD) is more prevalent in those with bipolar disorder (BD) than in the general population, with rates of PTSD as high as 55% in some BD cohorts. Despite this, little research explores the effects of pharmacotherapy treatments in those with comorbid BD…

  3. Journal Article Full text

    The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial

    Russell, Samantha E.; Skvarc, David R.; Mohebbi, Mohammadreza et al.

    Clin Psychopharmacol Neurosci · 2023 · English · PubMed Central

    OBJECTIVE: N-acetylcysteine (NAC) is a novel therapeutic agent with multiple mechanisms of action in the central nervous system and a favourable side effect profile. Clinical evidence indicates that adjunctive NAC may reduce the severity of depressive symptoms in individuals with major depressive…

  4. Journal Article Full text

    The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial

    Dean, Olivia M.; Cotton, Susan M.; Ashton, Melanie M. et al.

    Br J Psychiatry · 2025 · English · PubMed Central

    BACKGROUND: Bipolar depression remains difficult to treat, and people often experience ongoing residual symptoms, decreased functioning and impaired quality of life. Adjunctive therapies targeting novel pathways can provide wider treatment options and improve clinical outcomes. Garcinia mangostana…